Companies / Estonia
Growth Of Estonian Pharmaceutical Market Slows
March 2006 | Company Finance AlertSales of pharmaceuticals in Estonia grew by 5% to EEK2bn (US$153.7mn) in 2005, with Q4 revenue contributing almost 30% of the total.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
